Similar articles

• Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men.

  Flaharty KK, Caro J, Erslev A, Whalen JJ, Morris EM, Bjornsson TD, Vlasses PH. Flaharty KK, et al. Clin Pharmacol Ther. 1990 May;47(5):557-64. doi: 10.1038/clpt.1990.76. Clin Pharmacol Ther. 1990. PMID: 2188770 Clinical Trial.
• Pharmacokinetics of epoetin (recombinant human erythropoietin) after long term therapy in patients undergoing haemodialysis and haemofiltration.

  Gladziwa U, Klotz U, Bäumer K, Zollinger R, Mann H, Sieberth HG. Gladziwa U, et al. Clin Pharmacokinet. 1993 Aug;25(2):145-53. doi: 10.2165/00003088-199325020-00007. Clin Pharmacokinet. 1993. PMID: 8403738
• Clinical pharmacology of recombinant human erythropoietin (r-HuEPO).

  Flaharty KK. Flaharty KK. Pharmacotherapy. 1990 Mar-Apr;10(2 ( Pt 2)):9S-14S. Pharmacotherapy. 1990. PMID: 2345710
• Clinical pharmacokinetics of epoetin (recombinant human erythropoietin).

  Macdougall IC, Roberts DE, Coles GA, Williams JD. Macdougall IC, et al. Clin Pharmacokinet. 1991 Feb;20(2):99-113. doi: 10.2165/00003088-199120020-00002. Clin Pharmacokinet. 1991. PMID: 2029809 Review.
• Recombinant human erythropoietin.

  Jones EH. Jones EH. Am J Hosp Pharm. 1989 Nov;46(11 Suppl 2):S20-3. Am J Hosp Pharm. 1989. PMID: 2690606 Review.